Detalhe da pesquisa
1.
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
BMC Urol
; 24(1): 96, 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658905
2.
Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.
Exp Mol Pathol
; 131: 104860, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997051
3.
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors.
Acta Oncol
; 62(12): 1880-1889, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37938166
4.
Nomograms including the UBC® Rapid test to detect primary bladder cancer based on a multicentre dataset.
BJU Int
; 130(6): 754-763, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928524
5.
Molecular Diagnostic and Prognostication Assays for the Subtyping of Urinary Bladder Cancer Are on the Way to Illuminating Our Vision.
Int J Mol Sci
; 23(10)2022 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35628431
6.
Prediction of Response to Cisplatin-Based Neoadjuvant Chemotherapy of Muscle-Invasive Bladder Cancer Patients by Molecular Subtyping including KRT and FGFR Target Gene Assessment.
Int J Mol Sci
; 23(14)2022 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35887247
7.
Evaluation of Therapeutic Targets in Histological Subtypes of Bladder Cancer.
Int J Mol Sci
; 22(21)2021 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34768978
8.
Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation.
BMC Cancer
; 20(1): 230, 2020 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32188412
9.
External validation of a postoperative nomogram for the prediction of disease-specific survival in patients with papillary renal cell carcinoma using a large multicenter database.
Int J Clin Oncol
; 25(1): 145-150, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31471787
10.
Illumination of a Vision 2020-Urinary Based Biomarkers for Bladder Cancer on the Way to Clinical Decisions-Dream or Nightmare?
Int J Mol Sci
; 21(5)2020 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32121621
11.
Evaluating the Utility of Combined Bladder Cancer Biomarkers, the Molecular Prognostication of Tumor Subtypes, or What Else Is Needed to Illuminate Our Vision?
Int J Mol Sci
; 21(24)2020 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352845
12.
Activating Telomerase TERT Promoter Mutations and Their Application for the Detection of Bladder Cancer.
Int J Mol Sci
; 21(17)2020 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32839402
13.
Prognostic Role of Survivin and Macrophage Infiltration Quantified on Protein and mRNA Level in Molecular Subtypes Determined by RT-qPCR of KRT5, KRT20, and ERBB2 in Muscle-Invasive Bladder Cancer Treated by Adjuvant Chemotherapy.
Int J Mol Sci
; 21(19)2020 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33050010
14.
Establishment and Characterization of an Empirical Biomarker SS/PV-ROC Plot Using Results of the UBC® Rapid Test in Bladder Cancer.
Entropy (Basel)
; 22(7)2020 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33286501
15.
UBC® Rapid Test-A Urinary Point-of-Care (POC) Assay for Diagnosis of Bladder Cancer with a focus on Non-Muscle Invasive High-Grade Tumors: Results of a Multicenter-Study.
Int J Mol Sci
; 19(12)2018 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30513851
16.
Evaluation of a New Survivin ELISA and UBC® Rapid for the Detection of Bladder Cancer in Urine.
Int J Mol Sci
; 19(1)2018 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29324722
17.
Diagnostic and Prognostic Potential of MicroRNA Maturation Regulators Drosha, AGO1 and AGO2 in Urothelial Carcinomas of the Bladder.
Int J Mol Sci
; 19(6)2018 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-29857476
18.
UBC® Rapid Test for detection of carcinoma in situ for bladder cancer.
Tumour Biol
; 39(5): 1010428317701624, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468590
19.
Quality of life and pain relief in men with metastatic castration-resistant prostate cancer on cabazitaxel: the non-interventional 'QoLiTime' study.
BJU Int
; 119(5): 731-740, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27618249
20.
Presentation of a method at the Exploration Stage according to IDEAL: Percutaneous nephrolithotomy (PCNL) under local infiltrative anesthesia is a feasible and effective method - retrospective analysis of 439 patients.
Int J Med Sci
; 14(4): 302-309, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28553161